Radiotherapeutic Options for Symptom Control in Breast Cancer
Identifieur interne : 004778 ( Pmc/Curation ); précédent : 004777; suivant : 004779Radiotherapeutic Options for Symptom Control in Breast Cancer
Auteurs : Birgitt Van Oorschot [Allemagne] ; Gabriele Beckmann [Allemagne] ; Wolfgang Schulze [Allemagne] ; Dirk Rades [Allemagne] ; Petra Feyer [Allemagne]Source :
- Breast Care [ 1661-3791 ] ; 2011.
Abstract
The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30–50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.
Url:
DOI: 10.1159/000324564
PubMed: 21547021
PubMed Central: 3083266
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004779
Links to Exploration step
PMC:3083266Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Radiotherapeutic Options for Symptom Control in Breast Cancer</title><author><name sortKey="Van Oorschot, Birgitt" sort="Van Oorschot, Birgitt" uniqKey="Van Oorschot B" first="Birgitt" last="Van Oorschot">Birgitt Van Oorschot</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department of Radiation Oncology, University of Würzburg, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University of Würzburg, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Beckmann, Gabriele" sort="Beckmann, Gabriele" uniqKey="Beckmann G" first="Gabriele" last="Beckmann">Gabriele Beckmann</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department of Radiation Oncology, University of Würzburg, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University of Würzburg, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Schulze, Wolfgang" sort="Schulze, Wolfgang" uniqKey="Schulze W" first="Wolfgang" last="Schulze">Wolfgang Schulze</name><affiliation wicri:level="1"><nlm:aff id="aff2">Palliative Ward, Clinical Center Bayreuth, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Palliative Ward, Clinical Center Bayreuth, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Rades, Dirk" sort="Rades, Dirk" uniqKey="Rades D" first="Dirk" last="Rades">Dirk Rades</name><affiliation wicri:level="1"><nlm:aff id="aff3">Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Feyer, Petra" sort="Feyer, Petra" uniqKey="Feyer P" first="Petra" last="Feyer">Petra Feyer</name><affiliation wicri:level="1"><nlm:aff id="aff4">Radiation Oncology, Clinic for Radiotherapy, Nuclear Medicine Vivantes – Clinical Center Neukölln, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Radiation Oncology, Clinic for Radiotherapy, Nuclear Medicine Vivantes – Clinical Center Neukölln, Berlin</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">21547021</idno><idno type="pmc">3083266</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083266</idno><idno type="RBID">PMC:3083266</idno><idno type="doi">10.1159/000324564</idno><date when="2011">2011</date><idno type="wicri:Area/Pmc/Corpus">004779</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004779</idno><idno type="wicri:Area/Pmc/Curation">004778</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">004778</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Radiotherapeutic Options for Symptom Control in Breast Cancer</title><author><name sortKey="Van Oorschot, Birgitt" sort="Van Oorschot, Birgitt" uniqKey="Van Oorschot B" first="Birgitt" last="Van Oorschot">Birgitt Van Oorschot</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department of Radiation Oncology, University of Würzburg, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University of Würzburg, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Beckmann, Gabriele" sort="Beckmann, Gabriele" uniqKey="Beckmann G" first="Gabriele" last="Beckmann">Gabriele Beckmann</name><affiliation wicri:level="1"><nlm:aff id="aff1">Department of Radiation Oncology, University of Würzburg, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University of Würzburg, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Schulze, Wolfgang" sort="Schulze, Wolfgang" uniqKey="Schulze W" first="Wolfgang" last="Schulze">Wolfgang Schulze</name><affiliation wicri:level="1"><nlm:aff id="aff2">Palliative Ward, Clinical Center Bayreuth, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Palliative Ward, Clinical Center Bayreuth, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Rades, Dirk" sort="Rades, Dirk" uniqKey="Rades D" first="Dirk" last="Rades">Dirk Rades</name><affiliation wicri:level="1"><nlm:aff id="aff3">Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin</wicri:regionArea></affiliation></author><author><name sortKey="Feyer, Petra" sort="Feyer, Petra" uniqKey="Feyer P" first="Petra" last="Feyer">Petra Feyer</name><affiliation wicri:level="1"><nlm:aff id="aff4">Radiation Oncology, Clinic for Radiotherapy, Nuclear Medicine Vivantes – Clinical Center Neukölln, Berlin, Germany</nlm:aff><country xml:lang="fr">Allemagne</country><wicri:regionArea>Radiation Oncology, Clinic for Radiotherapy, Nuclear Medicine Vivantes – Clinical Center Neukölln, Berlin</wicri:regionArea></affiliation></author></analytic><series><title level="j">Breast Care</title><idno type="ISSN">1661-3791</idno><idno type="eISSN">1661-3805</idno><imprint><date when="2011">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Summary</title><p>The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30–50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.</p></sec></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Breast Care (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Breast Care (Basel)</journal-id><journal-id journal-id-type="publisher-id">BRC</journal-id><journal-title-group><journal-title>Breast Care</journal-title></journal-title-group><issn pub-type="ppub">1661-3791</issn><issn pub-type="epub">1661-3805</issn><publisher><publisher-name>S. Karger GmbH</publisher-name><publisher-loc>Lörracherstrasse 16 a, P.O. Box · Postfach · Case postale, D–79095, Freiburg, Germany · Deutschland · Allemagne, Phone: +49 761 45 20 70, Fax: +49 761 4 52 07 14, information@karger.de</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">21547021</article-id><article-id pub-id-type="pmc">3083266</article-id><article-id pub-id-type="doi">10.1159/000324564</article-id><article-id pub-id-type="publisher-id">brc0006-0014</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article · Übersichtsarbeit</subject></subj-group></article-categories><title-group><article-title>Radiotherapeutic Options for Symptom Control in Breast Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>van Oorschot</surname><given-names>Birgitt</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Beckmann</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schulze</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rades</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Feyer</surname><given-names>Petra</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib></contrib-group><aff id="aff1"><sup>a</sup>Department of Radiation Oncology, University of Würzburg, Berlin, Germany</aff><aff id="aff2"><sup>b</sup>Palliative Ward, Clinical Center Bayreuth, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</aff><aff id="aff3"><sup>c</sup>Department of Radiation Oncology, University Hospital Schleswig-Holstein, Campus Lübeck, Berlin, Germany</aff><aff id="aff4"><sup>d</sup>Radiation Oncology, Clinic for Radiotherapy, Nuclear Medicine Vivantes – Clinical Center Neukölln, Berlin, Germany</aff><author-notes><corresp id="cor1">*Dr. med. Birgitt van Oorschot, Interdisciplinary Center Palliative Medicine, Department of Radiation Oncology, University of Würzburg, Josef-Schneider-Str. 11, 97080 Würzburg, Germany, Tel. +49 931 201-28857, Fax -28873, <email>oorschot_b@klinik.uni-wuerzburg.de</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2011</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>2</month><year>2012</year></pub-date><pmc-comment> PMC Release delay is 12 months and 0 days and was based on the
<volume>6</volume><issue>1</issue><fpage>14</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright © 2011 by S. Karger AG, Basel</copyright-statement><copyright-year>2011</copyright-year></permissions><abstract><sec><title>Summary</title><p>The majority of breast cancer patients will require radiation therapy at some time during the course of their disease. An estimated 30–50% of all radiation treatments are of palliative nature, either to alleviate symptoms or prophylactic to prevent deterioration of quality of life due to locally progressive disease. Radiotherapy is a locally effective tool, and typically causes no systemic and mostly mild acute side effects. The following article provides an overview of options and decision-making in palliative radiotherapy for symptom control.</p></sec></abstract><trans-abstract xml:lang="de"><sec><title>Zusammenfassung</title><p>Die Mehrzahl der Patientinnen mit Brustkrebs erhält im Krankheitsverlauf einmalig oder mehrfach eine lokale Strahlentherapie, 30–50% der Behandlungen erfolgen unter palliativer Zielsetzung, entweder zur Linderung belastender Symptome oder palliativ-präventiv zur Sicherung der Lebensqualität durch die Vermeidung lokaler Komplikationen oder eines lokalen, zeitbegrenzten Tumorprogresses. Strahlentherapie ist ein lokal wirksames Verfahren mit zumeist nur leichten Nebenwirkungen. Der vorliegende Artikel gibt einen Überblick über die Möglichkeiten der palliativen Strahlentherapie zur Symptomlinderung und über die medizinische Entscheidungsfindung.</p></sec></trans-abstract><kwd-group><title>Keywords</title><kwd>Radiotherapy</kwd><kwd>Breast cancer</kwd><kwd>Symptom control</kwd><kwd>Palliative care</kwd></kwd-group><counts><fig-count count="2"></fig-count><ref-count count="50"></ref-count><page-count count="6"></page-count></counts></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004778 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 004778 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Curation
|type= RBID
|clé= PMC:3083266
|texte= Radiotherapeutic Options for Symptom Control in Breast Cancer
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i -Sk "pubmed:21547021" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |